Approval · Notice of Compliance 5139 · 1995
METHOTREXATE: Notice of Compliance 5139
Issued July 31, 1995
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 5139
- Date
- July 31, 1995
- Company
- Wyeth-Ayerst Canada Inc.St. Laurent, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antimetabolite
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| METHOTREXATE | 02170698 | Marketed |
| METHOTREXATE | 02170655 | Cancelled Post Market |
| METHOTREXATE | 02170663 | Cancelled Post Market |
| METHOTREXATE | 02170671 | Cancelled Post Market |
| METHOTREXATE | 02177110 | — |
Medicinal ingredients
- METHOTREXATE SODIUM 2.5 MG per TAB
- METHOTREXATE SODIUM 20 MG per VIAL
- METHOTREXATE SODIUM 25 MG per ML
- METHOTREXATE SODIUM 10 MG per TAB